Hims & Hers Health (XSWX:HIMS) Accounts Payable: CHF401 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:HIMS Hims & Hers Health Inc XSWX:HIMS
78 GF Score
Price CHF23.56
GF Value CHF35.29
! 4 Warning Signs
View Full Analysis

What is Hims & Hers Health Accounts Payable?

Hims & Hers Health XSWX:HIMS 78 Accounts Payable is CHF401 Mil as of Jun. 2026. GuruFocus rates XSWX:HIMS with a GF Score™ of 78/100 and a GF Value™ of CHF35.29. The stock has 4 warning signs investors should review.

Hims & Hers Health's Accounts Payable for the quarter that ended in Jun. 2026 was CHF401 Mil.

Hims & Hers Health's quarterly Accounts Payable increased from Dec. 2025 (CHF114 Mil) to Mar. 2026 (CHF242 Mil) and increased from Mar. 2026 (CHF242 Mil) to Jun. 2026 (CHF401 Mil).

Hims & Hers Health's annual Accounts Payable increased from Dec. 2023 (CHF37 Mil) to Dec. 2024 (CHF81 Mil) and increased from Dec. 2024 (CHF81 Mil) to Dec. 2025 (CHF114 Mil).

Hims & Hers Health Accounts Payable Related Terms

Hims & Hers Health Accounts Payable Historical Data

* Premium members only.

The historical data trend for Hims & Hers Health's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hims & Hers Health Accounts Payable Chart

Hims & Hers Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial 18.09 30.15 37.25 81.30 114.18

Hims & Hers Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 85.39 157.96 114.18 241.60 400.69
XSWX:HIMS
78GF Score
Hims & Hers Health Inc XSWX:HIMS
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hims & Hers Health Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of CHF401 Mil mean?
Hims & Hers Health (XSWX:HIMS) has a Accounts Payable of CHF401 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Hims & Hers Health and its competitors.
Is Hims & Hers Health's Accounts Payable too high?
Hims & Hers Health's current Accounts Payable is CHF401 Mil. Overall, Hims & Hers Health has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Hims & Hers Health's Accounts Payable compare to LNTH and AMRX?
Hims & Hers Health's Accounts Payable of CHF401 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Hims & Hers Health and its competitors. Hims & Hers Health's current Accounts Payable is CHF401 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hims & Hers Health stock overvalued right now?
Hims & Hers Health (XSWX:HIMS) has a current Accounts Payable of CHF401 Mil. The stock's GF Value™ is CHF35.29, compared to a current price of CHF23.56 — trading 33.3% below its estimated fair value. The current Accounts Payable is CHF401 Mil. Hims & Hers Health's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Hims & Hers Health (XSWX:HIMS), the current Accounts Payable is CHF401 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hims & Hers Health (XSWX:HIMS) Overvalued in 2026?

Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued. The current stock price of CHF23.56 is trading 33.3% below its estimated GF Value™ of CHF35.29.

Key valuation signals for XSWX:HIMS:

  • Accounts Payable: CHF401 Mil
  • GF Value™: CHF35.29 vs. price of CHF23.56 (33.3% below fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the XSWX:HIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hims & Hers Health Business Description

Address 2269 Chestnut Street, No. 523, San Francisco, CA, USA, 94123
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
78GF Score

Get the complete analysis for XSWX:HIMS

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF23.56
Price
CHF35.29
GF Value